INTRODUCTION {#s1}
============

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease with a worldwide prevalence of 8.7-18.1% in children \[[@R1]\] and 1.5-10.2% in adults \[[@R2]\]. It is characterized by continual itchiness, flares and sleep disturbance, negatively regulating the occupational activities and social relationships of patients, the quality of life of patients and their families \[[@R3]\]. Studies have convinced of a combination of genetic and environmental factors in the pathogenesis of AD. Genetic evidence depicts a complex network comprising epidermal barrier dysfunctions and dysregulation of innate and adaptive immunity in this disease. It has been accepted that mutations in the human filaggrin (*FLG*) gene are the most significant and well-replicated genetic mutations related to AD. Some other mutations such as *SPINK5*, *SPRR3*, and *CLDN1* may also correlate with epidermal barriers linked to AD. Genetic variants are able to contribute to the abnormal innate and adaptive responses, such as mutations in IL-1 family cytokines and receptors genes, vitamin D pathway genes, Th2 cytokines genes \[[@R4]\]. A cataract is a clouding of the lens that reduces light transmission to the retina, and it decreases the visual acuity of the bearer. It is one of the severe ocular complications of AD manifested in the eyes. The general classification of cataract includes nuclear, cortical and posterior subcapsular subtypes. Here, we focused on a Chinese male with AD complicated with cataracts via the recently developed whole exome sequencing approach, which has been used to determine the genetic basis of rare diseases.

RESULTS {#s2}
=======

Clinical description {#s2_1}
--------------------

The patient was a 19 year-old Chinese male who was admitted to our hospital with the chief complaint of relapsing generalized skin rash and blurred vision in August, 2015. His rash began from 10 years ago, accompanied with diffuse red papules all over the body, white desquamation, and skin itchiness. He was diagnosed with AD, and treatment without corticosteroids was not effective. There were persistent skin lesions, with obvious itchiness. His skin became dry and flaking, and some area became hard and thick. Seven months ago, his binocular vision became gradually declined. When admitted, red papules and scratches were displayed on the face, neck, trunk, and four extremities, especially on the face and neck (Figure [1](#F1){ref-type="fig"}). Both eyelids were hard and thick. The right vision was 0.4, and the left vision was 0.1. Keratic precipitates were negative, but both lens were turbid (Figure [2](#F2){ref-type="fig"}), of which the right one was more severe than the left. Hemogram analysis revealed eosinophile granulocyte 0.8×10^9^/l (12.1% in WBC), and immunological studies showed that expression of IgE was strongly elevated (\>3000.00IU/ml). Other investigations such as expression of complements, immune complex, subpopulation of T cells, anti-double stranded DNA antibody, anti-nuclear antibody were normal. Serum allergen test indicated that combination of willow/poplar/elm, crab, shrimp, combination of dermatophagoides pteronyssinus/dermatophagoides culinae were positive allergens. He has a history of eczema and house dust allergy. Interestingly, his father and grandma were diagnosed with AD, respectively (Figure [3](#F3){ref-type="fig"}).

![Appearance of red papules and scratches in the young patient](oncotarget-08-59446-g001){#F1}

![Anterior subcapsular cataracts and posterior subcapsular cataracts in both lens](oncotarget-08-59446-g002){#F2}

![Family pedigree of the atopic dermatitis](oncotarget-08-59446-g003){#F3}

Genetic analysis {#s2_2}
----------------

Due to the rarity of cataract occurred in this young male with AD, we hypothesized that an underlying genetic alteration might be present in this patient. We discussed the genetic relationship between the patient and his parents by whole exome sequencing. In order to discover the candidate mutations of AD, we searched for the genes both mutated in this patient and his father but not in his mother. Results showed that 162 genes were both mutated in this patient and his father but not in his mother (Table [1](#T1){ref-type="table"}, [Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

###### List of 162 genes both mutated in the patient and his father by whole exome sequencing

  Chromosome   Position    Gene          SNP                 Chromosome   Position    Gene         SNP           
  ------------ ----------- ------------- ------------- ----- ------------ ----------- ------------ ------------- -----
  chr1         93646190    *TMED5*       rs185712821   C/T   chr10        75563726    *NDST2*      NA            C/T
  chr1         45271238    *PLK3*        rs55654497    G/A   chr11        5537592     *UBQLNL*     rs142657773   G/C
  chr1         162569107   *UAP1*        rs190156359   T/A   chr11        74915493    *SLCO2B1*    rs192050675   C/A
  chr1         214537946   *PTPN14*      rs200340171   G/A   chr11        78369215    *TENM4*      rs185503085   C/T
  chr1         109260438   *FNDC7*       NA            T/C   chr11        123988461   *VWA5A*      rs202202178   A/T
  chr1         158533225   *OR6P1*       NA            C/T   chr11        124266877   *OR8B3*      rs183842912   A/C
  chr1         16907303    *NBPF1*       rs681623      C/T   chr11        10585620    *LYVE1*      NA            G/T
  chr1         17083872    *MST1L*       rs11545933    G/A   chr11        118376389   *KMT2A*      NA            C/T
  chr1         17263277    *CROCC*       rs200228265   G/A   chr11        130060375   *ST14*       NA            C/T
  chr1         181019227   *MR1*         NA            G/A   chr11        3726498     *NUP98*      NA            G/A
  chr1         232561368   *SIPA1L2*     NA            C/A   chr11        6661388     *DCHS1*      rs147698268   G/A
  chr1         23637401    *HNRNPR*      NA            C/T   chr11        71249529    *KRTAP5-8*   rs200162819   G/A
  chr1         248813827   *OR2T27*      rs1782241     T/C   chr12        6669359     *NOP2*       rs142370738   G/C
  chr1         33237103    *KIAA1522*    NA            C/T   chr12        7475081     *ACSM4*      rs7485773     C/T
  chr1         57411713    *C8B*         NA            G/C   chr12        105464439   *ALDH1L2*    rs199841702   G/C
  chr1         86355260    *COL24A1*     NA            C/G   chr12        109217071   *SSH1*       rs140582047   T/A
  chr1         9780232     *PIK3CD*      NA            G/A   chr12        110221524   *TRPV4*      rs55728855    C/T
  chr2         90249249    *IGKV1D-43*   NA            T/C   chr12        112150408   *ACAD10*     rs145407775   C/T
  chr2         113343610   *CHCHD5*      rs199612227   A/G   chr12        124097777   *DDX55*      rs117200049   G/A
  chr2         209108226   *IDH1*        rs186787509   T/C   chr12        108956430   *ISCU*       NA            G/C
  chr2         233735070   *C2orf82*     rs200597442   C/G   chr12        11183661    *TAS2R31*    NA            C/A
  chr2         152484095   *NEB*         NA            C/G   chr12        12966365    *DDX47*      NA            G/A
  chr2         179466289   *TTN*         NA            C/T   chr12        48104624    *ENDOU*      NA            C/T
  chr2         187627500   *FAM171B*     NA            A/G   chr12        52885339    *KRT6A*      rs199613662   C/T
  chr2         233675986   *GIGYF2*      NA            A/G   chr12        6950473     *GNB3*       NA            C/T
  chr2         73315216    *RAB11FIP5*   NA            A/T   chr13        103419820   *TEX30*      rs200314758   T/C
  chr2         97877478    *ANKRD36*     rs10194525    G/A   chr13        96242562    *DZIP1*      NA            T/G
  chr3         7728055     *GRM7*        rs182447901   C/T   chr14        45432003    *FAM179B*    rs200775208   C/T
  chr3         33644578    *CLASP2*      rs117166070   C/T   chr14        68241828    *ZFYVE26*    rs193244014   G/C
  chr3         49751251    *RNF123*      rs117758999   G/A   chr14        105415264   *AHNAK2*     rs201041268   G/A
  chr3         112648174   *CD200R1*     rs188572017   A/T   chr14        32256995    *NUBPL*      NA            G/A
  chr3         151107788   *MED12L*      rs199780529   T/C   chr14        70925106    *ADAM21*     NA            T/C
  chr3         124351317   *KALRN*       NA            G/A   chr15        45456025    *DUOX1*      rs186783799   G/A
  chr3         132319977   *CCRL1*       NA            G/A   chr15        89402346    *ACAN*       rs188663484   T/C
  chr3         40442466    *ENTPD3*      rs140869368   G/A   chr16        21994499    *UQCRC2*     NA            T/A
  chr4         42119545    *BEND4*       rs187366202   G/T   chr16        15761154    *NDE1*       rs147283674   C/T
  chr4         47788868    *CORIN*       rs186748019   C/A   chr16        55530864    *MMP2*       rs28730814    G/A
  chr4         52948557    *SPATA18*     rs184617860   C/T   chr16        18849442    *SMG1*       NA            G/A
  chr4         186291928   *LRP2BP*      NA            C/T   chr16        2287576     *DNASE1L2*   NA            C/T
  chr4         4190576     *OTOP1*       rs2215642     C/G   chr16        28846489    *ATXN2L*     NA            T/C
  chr5         38451559    *EGFLAM*      rs140968262   A/G   chr16        30100451    *TBX6*       rs202193096   G/A
  chr5         94814011    *TTC37*       rs143227096   C/A   chr16        456349      *DECR2*      NA            C/T
  chr5         137722246   *KDM3B*       rs184734460   C/G   chr16        46637519    *SHCBP1*     NA            A/G
  chr5         178507048   *ZNF354C*     rs116562180   C/G   chr16        67991689    *SLC12A4*    NA            G/A
  chr5         128442753   *ISOC1*       NA            G/T   chr16        71163611    *HYDIN*      NA            T/G
  chr5         149357850   *SLC26A2*     NA            G/T   chr16        71961625    *IST1*       NA            C/G
  chr5         171341357   *FBXW11*      NA            G/T   chr16        84213027    *TAF1C*      NA            C/G
  chr6         26056145    *HIST1H1C*    rs79483116    G/A   chr17        76166705    *SYNGR2*     NA            G/A
  chr6         27277365    *POM121L2*    rs61736085    G/A   chr17        36719794    *SRCIN1*     rs118094989   C/A
  chr6         39847207    *DAAM2*       rs139876341   A/G   chr17        40714796    *COASY*      rs200009135   G/C
  chr6         43017728    *CUL7*        rs146808129   C/A   chr17        48916935    *WFIKKN2*    rs35300894    G/A
  chr6         83838955    *DOPEY1*      rs188246058   A/C   chr17        55918596    *MRPS23*     rs117734846   C/T
  chr6         160485490   *IGF2R*       rs8191859     G/A   chr17        73096776    *SLC16A5*    rs116126425   G/A
  chr6         119628121   *MAN1A1*      NA            C/T   chr17        11461158    *SHISA6*     NA            A/G
  chr6         143825320   *FUCA2*       NA            A/G   chr17        12920199    *ELAC2*      rs140665334   G/A
  chr6         34512160    *SPDEF*       rs375427681   G/A   chr17        14139300    *CDRT15*     rs11867613    A/G
  chr6         34802049    *UHRF1BP1*    rs368713702   A/G   chr17        14204942    *HS3ST3B1*   NA            T/C
  chr6         39893446    *MOCS1*       rs377167949   G/A   chr17        26823582    *SLC13A2*    NA            G/A
  chr7         75617513    *TMEM120A*    rs372363121   C/T   chr17        2966032     *OR1D5*      rs2676564     C/G
  chr7         141464509   *TAS2R3*      NA            T/C   chr17        5036211     *USP6*       rs201674756   C/T
  chr7         144096938   *NOBOX*       NA            G/A   chr17        74869016    *MGAT5B*     NA            G/A
  chr7         148801869   *ZNF425*      NA            C/G   chr18        72913819    *ZADH2*      rs191356988   A/G
  chr7         2689594     *TTYH3*       NA            G/T   chr18        44584631    *KATNAL2*    NA            C/T
  chr7         2962827     *CARD11*      rs3735133     G/A   chr19        50028070    *FCGRT*      rs374439544   C/T
  chr8         8748876     *MFHAS1*      rs201875377   C/A   chr19        54743747    *LILRA6*     rs10403230    C/G
  chr8         17928855    *ASAH1*       rs11538152    G/A   chr19        4504673     *PLIN4*      rs201143997   G/A
  chr8         21766971    *DOK2*        rs202013016   G/A   chr19        15730502    *CYP4F8*     rs61746468    C/T
  chr8         42711517    *RNF170*      rs147488061   T/C   chr19        15839677    *OR10H2*     NA            T/C
  chr8         107691450   *OXR1*        rs200863692   A/G   chr19        18119274    *ARRDC2*     NA            G/A
  chr8         146067346   *ZNF7*        NA            A/G   chr19        22846981    *ZNF492*     NA            A/C
  chr8         52733228    *PCMTD1*      rs73592211    G/A   chr19        40743901    *AKT2*       NA            C/T
  chr8         70541824    *SULF1*       NA            C/T   chr19        43420636    *PSG6*       rs370759098   G/A
  chr9         2719083     *KCNV2*       rs143382624   G/C   chr19        58370766    *ZNF587*     rs77577775    G/A
  chr9         18776971    *ADAMTSL1*    rs117558542   G/A   chr20        31685424    *BPIFB4*     NA            T/C
  chr9         19345978    *DENND4C*     rs145052586   G/A   chr21        33690064    *URB1*       rs145519835   C/T
  chr9         84226764    *TLE1*        rs141959893   C/T   chr21        37584306    *DOPEY2*     rs117132686   C/A
  chr9         139750000   *MAMDC4*      rs200545888   T/C   chr21        19666690    *TMPRSS15*   NA            C/T
  chr9         131670227   *LRRC8A*      NA            C/T   chr22        22673302    *IGLV5-52*   NA            C/T
  chr10        25314128    *THNSL1*      rs78131600    C/T   chr22        20127408    *ZDHHC8*     rs200408305   A/G
  chr10        63810739    *ARID5B*      rs201704836   G/A   chr22        46725974    *GTSE1*      rs188655025   C/G
  chr10        128192832   *C10orf90*    NA            C/T   chrX         2833605     *ARSD*       rs111939179   C/T

SNP, single nucleotide polymorphism; NA, not available.

We used OMIM database and GeneCards Database to further interpret these genes and found that 4 genes among the 162 genes might have relationship with the predisposition and/or oncogenesis of AD (Figure [4](#F4){ref-type="fig"}). To find the candidate mutations of atopic cataracts, we searched for the genes only in this patient without in his parents. We found 10 genes mutated in this patient only without in his parents (Table [2](#T2){ref-type="table"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). Intriguingly, we compared these genes in this special patient with the patients those had been diagnosed with cataracts and had genes mutation, so as to discuss whether these 10 genes are belonging to this special kind of disease. After analyzing the available evidence, we found no data that may suggest these genes have been reported to correlate with cataracts. It is possible that these genes may uniquely belong to AD complicated with cataracts.

![Gene prediction scores of the four genes and residual variation intolerance score of the genes](oncotarget-08-59446-g004){#F4}

###### List of 10 genes mutated in the patient without in his parents by whole exome sequencing

  Chromosome   Position    Gene            SNP           
  ------------ ----------- --------------- ------------- -----
  chr12        11183066    *TAS2R31*       rs138895028   A/T
  chr15        22473171    *IGHV4OR15-8*   NA            A/G
  chr17        16068287    *NCOR1*         rs201932638   A/T
  chr19        33490566    *RHPN2*         rs74582927    T/C
  chr1         16890607    *NBPF1*         rs200783506   G/A
  chr22        22730788    *IGLV5-45*      NA            G/A
  chr22        22730800    *IGLV5-45*      rs114116194   A/C
  chr2         90249202    *IGKV1D-43*     NA            G/A
  chr2         90249205    *IGKV1D-43*     NA            A/C
  chr5         140594470   *PCDHB13*       rs17844610    G/A
  chr7         142149078   *TRBV5-5*       NA            T/G
  chr7         142149017   *TRBV5-5*       NA            G/C
  chr7         142149029   *TRBV5-5*       NA            T/G
  chr7         142149030   *TRBV5-5*       NA            C/G
  chr7         142149058   *TRBV5-5*       NA            T/A
  chr7         142149059   *TRBV5-5*       NA            T/C
  chr7         142149060   *TRBV5-5*       NA            T/C
  chr7         142149066   *TRBV5-5*       NA            A/C
  chr7         142149071   *TRBV5-5*       NA            T/C
  chr7         142149072   *TRBV5-5*       NA            G/A
  chr7         142149075   *TRBV5-5*       NA            A/G
  chr7         142149086   *TRBV5-5*       NA            G/A
  chr7         142149092   *TRBV5-5*       NA            T/A
  chr7         142149101   *TRBV5-5*       rs199978351   A/G
  chr9         33385750    *AQP7*          rs114484742   C/T

SNP, single nucleotide polymorphism; NA, not available.

DISCUSSION {#s3}
==========

Here, we presented a rare case of AD with cataract, and familial analysis by whole exome sequencing suggested that the pathogenesis of AD was related to genetic factors. Atopic cataract was firstly described in detail in 1936, where the author demonstrated the association of juvenile cataract with AD in 10 out of 101 AD patients, the mean age was 22 year-old, similar to our findings \[[@R5]\]. From 1940 to 1953, an ophthalmological check in 1,158 AD patients showed typical atopic cataract in 136 patients (11.7%) including 79 cases of visual disturbance \[[@R6]\]. To date, literatures describing cataracts in AD are mainly from Asian populations, including the Japanese population reporting the incidence of atopic cataracts around 10-15% \[[@R7]\], Filipino population \[[@R8]\] and Singapore population without Chinese population. Based on this, it seems that a greater interest may exist in Asians, or the prevalence and significance of this disease is greater in these populations. We firstly reported cataracts in a Chinese patient with AD with cataract. Interestingly, his father and his grandma are also AD patients.

It is known that cataract may develop as a result of aging, metabolic disorders, trauma, or heredity. Location of the cataract in the lens regulates visual acuity. There are two types of cataracts in AD patients in subcapsular region, anterior subcapsular cataracts (ASCs) and posterior subcapsular cataracts (PSCs). The literatures about ASCs or PSCs development in AD patients are inconsistent. Disease onset of ASCs is typically rapid, shieldlike bilateral visual impairment \[[@R4], [@R9]\], therefore, presentation of ASCs seems to be the "classic" cataract because ASCs in the absence of AD is not common \[[@R9]\]. On the contrary, some investigations showed that PSCs may be more common in AD patients \[[@R9]--[@R12]\]. In a 29 year-old male, AD presented with bilateral ASCs \[[@R13]\]. Histopathologic analysis of the ASCs tissues indicated a fibrous and amorphous mass, most likely extracellular matrix owing to the presence of irregularly arranged bundled strands of fibrils, typical of collagen. Lens epithelial cells (LECs) at the plaque were densely packed and myofibroblast-like and immunoreactive for alpha-smooth muscle actin. Similarly, a 6 year-old African American girl presented with an uncontrolled flare of AD, and her medical history was significant for asthma and allergic rhinitis with a family history of AD \[[@R14]\]. This was in agreement with our study that the male patient\'s father and grandmother were also AD. Our results showed that ASCs and PSCs were both existed in the left and right lens of the patient (Figure [2](#F2){ref-type="fig"}).

Although the pathogenesis of AD complicated with cataract has not been clearly elucidated, severe lesions of AD located over the face may be a critical factor in the development of atopic cataracts. In addition, AD complicated with cataracts may correlate with prolonged usage of corticosteroids and repetitive periorbital scratching \[[@R11]\]. Physical examination of the present patient showed a scratch on the face, neck, trunk, and four extremities, especially on the face and neck, suggesting that AD complicated with cataract in this patient may correlate with scratching. However, several studies reported that the presence of cataracts (both ASCs and PSCs) were not correlated with the disease onset, severity, or duration of AD \[[@R15], [@R16]\], and the clinical features of AD patients who developed cataracts were similar to the patients who did not have. It is notable that cataract was seen in some patients with only mild facial involvement \[[@R16], [@R17]\]. On the other hand, systemic corticosteroids are known to cause ocular complications. It is reported that incidence of cataract is dose and treatment duration dependent, where the patients received the equivalent of prednisone, 10 to 15 mg/d for at least 1 year displayed the greatest risk \[[@R18]\]. However, Niwa, et al discussed the incidence of cataract among 3 groups of AD patients \[[@R11]\]. The patients were treated with topical corticosteroids, or treated with both topical and systemic corticosteroids, or corticosteroid-naive patients, respectively. The authors found no difference among these groups. Interestingly, there are 37 patients developed cataract, by which 86% showed posterior cataract \[[@R11]\]. This finding was similar to our study, where the patient had no history of corticosteroids. Tatham, et al reported two boys about 10 year-old diagnosed with widespread AD of the face, neck, trunk and limbs. After diagnosis and treatment with topical steroids for 2 years, both of them complained of gradual onset of blurred vision in both eyes, ophtalmic testing found PSCs in these patients, suggesting that AD and topical corticosteroids may be associated with cataracts in children \[[@R19]\]. Together, whether usage of corticosteroids and scratching may be susceptible factors to AD complicated with cataract is still needed to be clarified in the future with large scales of patients.

Genetic epidemiologic studies on monozygotic twins \[[@R20]\], and genetic association studies indicated a genetic susceptibility for AD \[[@R21]\]. In the present study, four genes including *CORIN*, *CARD11*, *MMP2*, *DNASE1L*, which were previously reported to be risk factors for AD \[[@R22]--[@R25]\], were also mutated in this patient and his father. *CARD11* encodes CARMA1, an essential scaffold protein for lymphocyte activation via T cell receptor and B cell receptor signaling \[[@R26]\]. CARMA1 plays important roles in T cell differentiation, regulation of JunB, GATA3 and the subsequent generation of Th2 cell specific cytokines \[[@R27]\]. Mice that are homozygous for the mutation affecting CARMA1 showed gradual development of AD with high level of serum IgE \[[@R28]\]. Li, et al \[[@R29]\] showed that chronic loss of epidermal caspase-8 recapitulates many aspects of AD, such as a spongiotic phenotype whereby intercellular adhesion between epidermal keratinocytes is disrupted, adversely affecting tissue architecture and function. However, subcutaneous injection of matrix metalloproteinase-2 (MMP2) inhibitor strongly down-regulated the intercellular space found in the suprabasal layers of the epidermis \[[@R29]\]. Suppression of MMP2 also restored full length E-cadherin to normal levels and significantly decreased the amount of the cleaved E-cadherin C-terminal fragments product. Transepidermal water loss through the epidermis from caspase-8 conditional knockout mice treated with the MMP2 inhibitor was strongly reduced relative to controls, suggesting that suppression of MMP2 is able to abrogate the effect of caspase-8 knockout induced AD. In a whole exome sequencing study of early-onset AD from a Korean population, Heo, et al discussed family-specific candidate genetic variants from three separate families, and validated the possible genes in 112 AD patients and 61 controls. Results showed that three variants of the *COL6A6* gene appeared in all three families and were in close proximity to AD related loci on chromosome 3q21 \[[@R30]\]. The homozygous frequency for the rs16830494 minor allele (AA) and the rs59021909 (TT) allele and the rs200963433 heterozygous (CT) frequency were all higher in AD cases compared to controls, suggesting that COL6A6 variants may be risk factors for AD.

Matsuda, et al \[[@R7]\] discovered that -56 T allele in the *IFNGR1* promoter was significantly associated with an increased risk of ocular AD, especially of atopic cataracts. In our study, the whole exome sequencing revealed the -56 CT genotype in both the patient and his father, which contained -56 T allele, whereas his mother harbored -56 CC genotype. The *IFNGR1* gene promoter construct that contained the -56 T allele showed higher transcriptional activity in LECs than did the construct with the -56 C allele after stimulation with IFN-γ, and there was higher IFNGR1 expression in the LECs in atopic than in senile cataracts \[[@R7]\], indicating that the -56 T allele in the *IFNGR1* promoter leads to elevated *IFNGR1* transcriptional activity and represents a genetic risk factor for atopic cataracts. Hori, et al \[[@R25]\] investigated the role of PAI-1, IFN-γ downstream molecule in the pathogenesis of atopic cataracts. They found that the IFN-γ, PAI-1 and TGF-β1 were involved in the pathophysiology of atopic cataracts.

According to the OMIM database and GeneCards Database, we found 4 genes including *CARD11, PIK3CD, LILRB3, C8B*, may correlate with the pathogenesis of AD. Among them, *CARD11* had been reported to have relation with AD \[[@R24]\]. Phenolyzer were used to examine the association of these candidate genes with AD and we found that *PIK3CD*, *LILRB3*, *C8B* were in the same biosystem with *CARD11* in the record of NCBI\'s Biosystem. According to the result of residual variation intolerance score (RVIS) \[[@R31]\], *CARD11* had a RVIS score of-1.39 and a percentile of 4.33%, showing that it was amongst the 4.33% most intolerant of human gene (FDR = 1.87×10^-6^), and *PIK3CD*, the 2.72% most intolerant human gene (FDR = 8.11×10^-6^), had a score of -1.66, while *LILRB3* and *C8B* with positive scores had more common functional variation. The normalized RVIS of *CARD11* and *PIK3CD* was approximated to 1, indicating that these two genes were considered as "intolerant". *PIK3CD* had a HI score of 0.607 \[[@R32]\], suggesting that haploinsufficiency of the *PIK3CD* gene may associate with the pathogenesis of AD (Figure [4](#F4){ref-type="fig"}).

In conclusion, this is the first report of familial AD with cataracts, and the family-based whole exome sequencing found that 162 genes were both mutated in the young patient and his father, while 10 genes were only mutated in the young patient of AD complicated with cataracts. Further studies with large scale need to discuss the functional role of these genes in AD, especially in AD complicated with cataracts.

MATERIALS AND METHODS {#s4}
=====================

Subjects {#s4_1}
--------

There was a 19 year-old young male with AD accompanied with cataracts. His father was AD patient, while his mother was not AD or cataracts patient. All of them were recruited in this study. The grandma was also AD, because of impossibility, the grandma was not included. Patients were collected from the Department of Dermatology of the West China Hospital Sichuan University. AD patients met the diagnostic criteria of Hanifin and Rajka \[[@R33]\]. Data about demographic and clinical features were collected from hospital records or by questionnaire and reviewed by experienced physicians. All subjects gave their written consent to participate before study. This study was approved by the ethics committee of the Sichuan University.

DNA extraction and whole exome sequencing {#s4_2}
-----------------------------------------

EDTA anti-coagulated venous blood (10ml) was collected from the young male and his parents. The genomic DNA was extracted using the TIANamp Genomic DNA Kit (Tiangen Biotech, Beijing, China) following the manufacturer\'s protocol. Whole exome enrichment was performed using *Agilent SureSelect Human All Exon* Kit *50M* (*Agilent* Technologies, Santa Clara, CA, USA) and sequenced with the Illumina HiSeq 4000 System (HiSeq® 3000/4000 SBS Kit).

Sequence alignment, variant calling, and annotation {#s4_3}
---------------------------------------------------

The sequenced reads were aligned to the hg19 human reference genome sequence using BWA aln and BWA sampe, and removed PCR duplicates with PICARD. Variations were called by GATK HaplotypeCaller with default parameters, after calling genotyping were jointed together by GATK CombineGVCFs/GenotypeGVCFs. Variants were retained considering reads depth DP\>= 8, MQ \>=20. Beyond that, variants were annotated by ANNOVAR, filtered by position (non-synonymous or gain/loss of stops), VAF \< 0.005 (1000 genome project (2012) and HAPMAP), potential damaging effect (variants that were predicted as damaging variants by at least 2 databases, including SIFT, PolyPhen2 HDIV, PolyPhen2 HVAR, LRT, MutationTaste, MutationAssessor, FATHMM, GERP++, PhyloP and SiPhy).

SUPPLEMENTARY MATERIALS TABLES {#s5}
==============================
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